Type 1 Diabetes
1,185
136
184
743
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
220 trials with published results (19%)
Research Maturity
743 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.7%
56 terminated out of 1185 trials
93.0%
+6.5% vs benchmark
9%
110 trials in Phase 3/4
30%
220 of 743 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 743 completed trials
Clinical Trials (1185)
Closed Loop Glucose Control in a Simulated ICU Setting
Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
Supporting Meal Management in Type 1 Diabetes
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
Individualized Exercise Consultation in Type 1 Diabetes
School Partnered Collaborative Care (SPACE) Intervention for Children With Type 1 Diabetes
Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Two Way Crossover Closed Loop MPC vs Control IQ
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Type 1 Diabetes, Exercise and Mentoring Trial
AIDANET Pediatrics
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
French Prospective Multicentric Study in Real World
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm